Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatrics. 2007 Aug;120(2):405-18.

Management guidelines for mucopolysaccharidosis VI.

Author information

  • 1Medical Genetics Service, Hospital de ClĂ­nicas de Porto Alegre, Porto Alegre, Brazil.

Abstract

Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) is a lysosomal storage disease that is characterized by systemic clinical manifestations and significant functional impairment. Diagnosis and management are often challenging because of the considerable variability in symptom presentation and rate of progression. The optimal standard of care should be based on evidence from randomized, controlled trials, meta-analyses, systematic reviews, and expert opinion. In support of this goal, comprehensive management guidelines have been drafted by an international group of experts in the management of patients with mucopolysaccharidosis VI. The guidelines provide a detailed outline of disease manifestations by body system, recommendations for regular assessments, and an overview of current treatment options.

PMID:
17671068
DOI:
10.1542/peds.2006-2184
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center